Occurrence of Sjogren syndrome in a long-term survivor patient with metastatic colon carcinoma treated with GOLFIG regimen

被引：6
作者：
Tenti, Sara [1 ]
Correale, Pierpaolo [2 ]
Conca, Raffaele [2 ]
Pastina, Pierpaolo [2 ]
Fioravanti, Antonella [1 ]
机构：
[1] Azienda Univ, Osped Senese, Dept Clin Med & Immunol Sci, Rheumatol Unit, I-53100 Siena, Italy
[2] Azienda Univ, Osped Senese, Dept Oncol, Med Oncol Unit, I-53100 Siena, Italy
来源：
JOURNAL OF CHEMOTHERAPY | 2012年 / 24卷 / 04期
关键词：
COLORECTAL-CARCINOMA; STIMULATING FACTOR; CANCER PATIENTS; GEMCITABINE; CHEMOIMMUNOTHERAPY; OXALIPLATIN; ACID;
D O I：
10.1179/1973947812Y.0000000008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：245 / 246
页数：2
相关论文
共 7 条
[1]   Occurrence of autoimmunity in a long-term survivor with metastatic colon carcinoma treated with a new chemo-immunotherapy regimen [J].
Correale, P. ;
Fioravanti, A. ;
Bertoldi, I. ;
Montagnani, F. ;
Miracco, C. ;
Francini, G. .
JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) :278-281
[2]   Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer [J].
Correale, P. ;
Montagnani, F. ;
Miano, S. ;
Sciandivasci, A. ;
Pascucci, A. ;
Petrioli, R. ;
Testi, W. ;
Tanzini, G. ;
Francini, G. .
JOURNAL OF CHEMOTHERAPY, 2008, 20 (01) :119-125
[3]   A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma [J].
Correale, P ;
Messinese, S ;
Caraglia, M ;
Marsili, S ;
Piccolomini, A ;
Petrioli, R ;
Ceciarini, F ;
Micheli, L ;
Nencini, C ;
Neri, A ;
Vuolo, G ;
Guarnieri, A ;
Abbruzzese, A ;
Prete, SD ;
Giorgi, G ;
Francini, G .
BRITISH JOURNAL OF CANCER, 2004, 90 (09) :1710-1714
[4]   Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients [J].
Correale, P ;
Cusi, MG ;
Tsang, KY ;
Del Vecchio, MT ;
Marsili, S ;
La Placa, M ;
Intrivici, C ;
Aquino, A ;
Micheli, L ;
Nencini, C ;
Ferrari, F ;
Giorgi, G ;
Bonmassar, E ;
Francini, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :8950-8958
[5]   Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine plus FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial) [J].
Correale, Pierpaolo ;
Tagliaferri, Pierosandro ;
Fioravanti, Antonella ;
Del Vecchio, Maria Teresa ;
Remondo, Cinzia ;
Montagnani, Francesco ;
Rotundo, Maria Saveria ;
Ginanneschi, Chiara ;
Martellucci, Ignazio ;
Francini, Edoardo ;
Cusi, Maria Grazia ;
Tassone, Pierfrancesco ;
Francini, Guido .
CLINICAL CANCER RESEARCH, 2008, 14 (13) :4192-4199
[6]   Sjogren's syndrome [J].
Fox, RI .
LANCET, 2005, 366 (9482) :321-331
[7]  
Li XM, 2007, J RHEUMATOL, V34, P2438
1